Melatonin Supplementation as Adjuvant Therapy for the Prevention of Bronchopulmonary Dysplasia in Neonates
Background: Neonatal bronchopulmonary dysplasia (BPD) is a chronic chest disease caused by prolonged ventilation and oxygenation which leads to neonatal disability.<br />Methods: It was a prospective randomized clinical trial (RCT) (Study ID: TCTR20191211004) which was conducted in Tanta Unive...
Saved in:
Main Authors: | Mohamed Shawky Elfarargy (Author), Dina Adam Ali (Author), Ghada Mohammad Al-Ashmawy (Author) |
---|---|
Format: | Book |
Published: |
Mashhad University of Medical Sciences,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Therapy for the Prevention and Treatment of Bronchopulmonary Dysplasia
by: Anjali eIyengar, et al.
Published: (2015) -
Strategies for the prevention of bronchopulmonary dysplasia
by: Gianluca Dini, et al.
Published: (2024) -
MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY
by: I. V. Davydova, et al.
Published: (2012) -
Melatonin as an adjuvant therapy in preterm infants with neonatal sepsis, randomized trial
by: Zeinab A. El-Kabbany, et al.
Published: (2020) -
An Update on the Prevention and Management of Bronchopulmonary Dysplasia
by: Hennelly M, et al.
Published: (2021)